These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lipidic vector systems for gene transfer. Lee RJ; Huang L Crit Rev Ther Drug Carrier Syst; 1997; 14(2):173-206. PubMed ID: 9107521 [TBL] [Abstract][Full Text] [Related]
5. Liposome-based drug delivery systems. Langner M; Kral TE Pol J Pharmacol; 1999; 51(3):211-22. PubMed ID: 10600035 [TBL] [Abstract][Full Text] [Related]
6. A Recent Overview on Dermatological Applications of Liposomes. Kushwaha P; Saxena S; Shukla B Recent Pat Nanotechnol; 2021; 15(4):310-321. PubMed ID: 33087038 [TBL] [Abstract][Full Text] [Related]
7. The surface properties of phospholipid liposome systems and their characterisation. Jones MN Adv Colloid Interface Sci; 1995 Jan; 54():93-128. PubMed ID: 7832999 [TBL] [Abstract][Full Text] [Related]
8. Liposome technology for cardiovascular disease treatment and diagnosis. Bowey K; Tanguay JF; Tabrizian M Expert Opin Drug Deliv; 2012 Feb; 9(2):249-65. PubMed ID: 22235930 [TBL] [Abstract][Full Text] [Related]
9. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers. Ranade VV J Clin Pharmacol; 1989 Aug; 29(8):685-94. PubMed ID: 2674208 [TBL] [Abstract][Full Text] [Related]
10. Designing of 'intelligent' liposomes for efficient delivery of drugs. Voinea M; Simionescu M J Cell Mol Med; 2002; 6(4):465-74. PubMed ID: 12611636 [TBL] [Abstract][Full Text] [Related]
11. [Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes]. Budai M; Szógyi M Acta Pharm Hung; 2001; 71(1):114-8. PubMed ID: 11769091 [TBL] [Abstract][Full Text] [Related]
12. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. Bhatia A; Kumar R; Katare OP J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383 [TBL] [Abstract][Full Text] [Related]
13. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential. Gregoriadis G; Florence AT Drugs; 1993 Jan; 45(1):15-28. PubMed ID: 7680982 [TBL] [Abstract][Full Text] [Related]
14. The liposomal formulation of doxorubicin. Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375 [TBL] [Abstract][Full Text] [Related]
15. Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics. Awasthi VD; Garcia D; Klipper R; Goins BA; Phillips WT J Pharmacol Exp Ther; 2004 Apr; 309(1):241-8. PubMed ID: 14718581 [TBL] [Abstract][Full Text] [Related]
16. Encapsulated hemoglobin: current issues and future goals. Rudolph AS Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):347-60. PubMed ID: 8087251 [TBL] [Abstract][Full Text] [Related]
17. Targeted liposomal drug delivery in cancer. Medina OP; Zhu Y; Kairemo K Curr Pharm Des; 2004; 10(24):2981-9. PubMed ID: 15379663 [TBL] [Abstract][Full Text] [Related]
18. Size dependent variations of phospholipid based vesicular drug carriers in systemic drug activity. Mukherjee B; Mondal L; Chakraborty S; Paul P; Choudhury A; Bhattacharya S; Hossain CM Curr Pharm Biotechnol; 2015; 16(4):380-91. PubMed ID: 25658382 [TBL] [Abstract][Full Text] [Related]
19. Use of liposomes as injectable-drug delivery systems. Ostro MJ; Cullis PR Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806 [TBL] [Abstract][Full Text] [Related]
20. Long-circulating sterically stabilized liposomes in the treatment of infections. Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]